Personal information

Verified email domains

Activities

Employment (1)

Institut de Cancérologie de Lorraine: Vandœuvre-lès-Nancy, FR

2022-10-01 to 2025-09-30 | PhD Student (Service de Biologie Moléculaire des Tumeurs)
Employment
Source: Self-asserted source
Margaux BETZ

Education and qualifications (1)

Université de Lorraine: Vandoeuvre les Nancy, FR

2020-09-01 to 2022-08-01 | Master in Life Science, with specialty in Biotechnology and Molecule Engineering (Biology)
Education
Source: Self-asserted source
Margaux BETZ

Works (6)

Decoding mutational signatures in breast cancer: Insights from a multi-cohort study

Translational Oncology
2025-03 | Journal article
Contributors: Margaux Betz; Andréa Witz; Julie Dardare; Cassandra Michel; Vincent Massard; Romain Boidot; Pauline Gilson; Jean-Louis Merlin; Alexandre Harlé
Source: check_circle
Crossref

DDB2 expression lights the way for precision radiotherapy response in PDAC cells, with or without olaparib

Cell Death Discovery
2024-09-27 | Journal article
Contributors: Julie Dardare; Andréa Witz; Margaux Betz; Aurélie François; Laureline Lamy; Marie Husson; Jessica Demange; Marie Rouyer; Aurélien Lambert; Jean-Louis Merlin et al.
Source: check_circle
Crossref

Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?

Clinical and experimental medicine
2024-01 | Journal article
Contributors: Witz A; Dardare J; Betz M; Gilson P; Merlin JL; Harlé A
Source: Self-asserted source
Margaux BETZ via Europe PubMed Central

<i>ESR1</i> Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?

Cancers
2023-10 | Journal article | Author
Contributors: Margaux BETZ; Vincent Massard; Pauline Gilson; Andréa Witz; Julie Dardare; Alexandre Harlé; Jean-Louis MERLIN
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers.

Scientific reports
2023-08 | Journal article
Contributors: Gilson P; Pouget C; Belmonte R; Fadil S; Demange J; Rouyer M; Lacour J; Betz M; Dardare J; Witz A et al.
Source: Self-asserted source
Margaux BETZ via Europe PubMed Central

DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy.

Frontiers in oncology
2022-12 | Journal article
Contributors: Dardare J; Witz A; Betz M; Francois A; Meras M; Lamy L; Lambert A; Grandemange S; Husson M; Rouyer M et al.
Source: Self-asserted source
Margaux BETZ via Europe PubMed Central